DMRADamora Therapeutics Inc.
−1.6% today · +201.8% over a year
No score: too little data.
Quality, Stability: among the weakest. No dividend.
Damora Therapeutics Inc. (DMRA) belongs to the Health care sector and is listed on Nasdaq; country: Denmark. Its market value is about €1.2B. Over the past 12 months the price changed by +201.8%, with an annualised volatility of 163% and a largest fall of 47%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- 12-month trend (ex last month)supports the score · better than 99% of peers
- Volatility (1 y)weighs on the score · better than 1% of peers
- Share issuance (1 y)weighs on the score · better than 2% of peers
Red flags and notes
- Caution. At least one reverse split in the last three years. More in the glossary → At least one reverse split in the last three years.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 2.6
- Market cap (EUR)
- €1.2B
Profitability and debt
- Return on equity
- −99.7%
Dividends
- Dividend yield
- 0.00%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- −1.6%
- 1 month
- +4.1%
- 1 year
- +201.8%
- Volatility, 1 yr
- 162.7%
- Max drawdown, 1 yr
- −46.9%
- Beta
- 2.91
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| GHRSGH Research PLC | 1/10 | 0.0% | 47.9% |
|---|---|---|---|
| CRONCronos Group Inc. | 6/10 | 0.0% | 34.5% |
| DRTSAlpha Tau Medical Ltd. | 1/10 | 0.0% | 217.9% |
| ALVOAlvotech | 1/10 | 0.0% | −37.2% |
| QUREuniQure N.V. | 1/10 | 0.0% | −64.3% |
| URGNUroGen Pharma Ltd. | 1/10 | 0.0% | 67.2% |
| NVCRNovoCure Limited | 1/10 | 0.0% | 6.0% |
| CMPSCOMPASS Pathways Plc American Depository Shares | 1/10 | 0.0% | 87.5% |
News and filings
- Damora Therapeutics, Inc.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 10 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.